| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstract withdrawn
|
|
|
|
1 |
S1 |
p. 31
|
artikel
|
| 2 |
Abstract withdrawn
|
|
|
|
1 |
S1 |
p. 11
|
artikel
|
| 3 |
Administration of panobinostat is associated with increased IL-17A mRNA in the intestinal epithelium of HIV-1 patients
|
Christensen, A. Bjerg
|
|
|
1 |
S1 |
p. 35
|
artikel
|
| 4 |
Allogeneic stem cell transplantation in HIV-1 infected individuals
|
Wensing, A.M.J.
|
|
|
1 |
S1 |
p. 23-24
|
artikel
|
| 5 |
Antiretroviral drug activity in macaque PrEP breakthrough infections has only a transient effect on cell-associated SHIV DNA reservoirs
|
García-Lerma, J.G.
|
|
|
1 |
S1 |
p. 6
|
artikel
|
| 6 |
Antiviral therapy by targeting nanoparticles to CD4+ cells for the delivery of SIV-specific RNA-guided Cas9 nucleases
|
Giavedoni, L.
|
|
|
1 |
S1 |
p. 15
|
artikel
|
| 7 |
A pharmacologic basis for HIV persistence
|
Fletcher, C.
|
|
|
1 |
S1 |
p. 10
|
artikel
|
| 8 |
Approaches to discover latency-reversing agents
|
|
|
|
1 |
S1 |
p. 11
|
artikel
|
| 9 |
A subset of infectious proviruses persist and expand following activation ex vivo
|
Bui, J.K.
|
|
|
1 |
S1 |
p. 10-11
|
artikel
|
| 10 |
Asymptomatic cerebrospinal fluid viral escape during ART is associated with increased intrathecal immune activation
|
Eden, A.
|
|
|
1 |
S1 |
p. 33
|
artikel
|
| 11 |
A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
|
Ke, R.
|
|
|
1 |
S1 |
p. 29
|
artikel
|
| 12 |
Author index
|
|
|
|
1 |
S1 |
p. 43-45
|
artikel
|
| 13 |
CCR5- and CXCR4-tropic HIVs infect CD4+ hematopoietic stem and progenitor cells in vitro and in optimally treated people
|
Sebastian, N.
|
|
|
1 |
S1 |
p. 33-34
|
artikel
|
| 14 |
CD8+ sensing relies on nanomolar levels of antigen presented upon HIV-1 reactivation
|
Ruiz, A.
|
|
|
1 |
S1 |
p. 9
|
artikel
|
| 15 |
Cell-associated HIV-1 DNA and viral load evaluation in HIV-1 infected children before and after combination antiretroviral therapy initiation
|
Moragas, M.
|
|
|
1 |
S1 |
p. 27
|
artikel
|
| 16 |
Cellular HIV RNA/DNA as biomarkers of inducible virion production
|
Cillo, A.
|
|
|
1 |
S1 |
p. 3
|
artikel
|
| 17 |
Challenges in designing clinical trials in cure research
|
Eron, J.
|
|
|
1 |
S1 |
p. 12
|
artikel
|
| 18 |
Characterization of humanized NSG mice to evaluate latency
|
Satheesan, S.
|
|
|
1 |
S1 |
p. 19
|
artikel
|
| 19 |
CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent
|
Macedo, A.
|
|
|
1 |
S1 |
p. 14
|
artikel
|
| 20 |
Clones of SIV-infected cells are present in spleen and lymph nodes in rhesus macaques
|
Hughes, S.H.
|
|
|
1 |
S1 |
p. 1
|
artikel
|
| 21 |
Co-culture of T-cells with dendritic cells facilitates HIV latency in proliferating CD4+ T-cells: implications for the establishment and reversal of latency
|
Kumar, N.
|
|
|
1 |
S1 |
p. 20
|
artikel
|
| 22 |
Co-expression of multiple inhibitory receptors on CD8+ T cells in viremic and ART-suppressed HIV-1(+) individuals
|
Macatangay, B.
|
|
|
1 |
S1 |
p. 36
|
artikel
|
| 23 |
Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs
|
Dampier, W.
|
|
|
1 |
S1 |
p. 39-40
|
artikel
|
| 24 |
Constraints on the dynamics of HIV-1 lifecycle elucidated by treatment with an integrase inhibitor reveal a subset of cells with very slow integration
|
Ribeiro, R.M.
|
|
|
1 |
S1 |
p. 23
|
artikel
|
| 25 |
Correlation between HIV-2 RNA and HIV-2 total DNA levels
|
Charpentier, C.
|
|
|
1 |
S1 |
p. 28-29
|
artikel
|
| 26 |
Cyanotriazoles activate latent HIV and strongly synergize with proteasome inhibitors ex vivo in resting CD4 T cells from suppressed HIV+ donors
|
Murry, J.
|
|
|
1 |
S1 |
p. 12
|
artikel
|
| 27 |
Dendritic cell induced “kick” of latent HIV-1 in vitro during cART
|
Mailliard, R.B.
|
|
|
1 |
S1 |
p. 17
|
artikel
|
| 28 |
Detection and enrichment to near purity of rare HIV-1 infected cells by PrimeFlow RNA
|
Romerio, F.
|
|
|
1 |
S1 |
p. 5
|
artikel
|
| 29 |
Detection of replication competent HIV from latently infected CD4+ T cells
|
Fun, A.
|
|
|
1 |
S1 |
p. 26
|
artikel
|
| 30 |
Developing and applying ultrasensitive p24 protein immunoassay for HIV latency
|
Howell, B.J.
|
|
|
1 |
S1 |
p. 5
|
artikel
|
| 31 |
Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
|
Clutton, G.
|
|
|
1 |
S1 |
p. 8-9
|
artikel
|
| 32 |
Differential efficacy of antiretroviral drugs in HIV-1 infected human microglia
|
Asahchop, E.L.
|
|
|
1 |
S1 |
p. 37
|
artikel
|
| 33 |
Diverse proviral structure of HIV integrants in clonally expanded cells
|
Simonetti, F.R.
|
|
|
1 |
S1 |
p. 31
|
artikel
|
| 34 |
Diversity changes in blood HIV-1 DNA reservoir after combination of chemotherapy and autologous hematopoietic stem cell transplantation for lymphoma
|
Delagreverie, H.
|
|
|
1 |
S1 |
p. 30
|
artikel
|
| 35 |
Donor-to-donor variation in the host gene expression response to SAHA
|
Moesker, B.
|
|
|
1 |
S1 |
p. 37
|
artikel
|
| 36 |
Dual-affinity re-targeting (DART) proteins overcome viral diversity to deplete the latent HIV-1 reservoir
|
Sung, J.M.
|
|
|
1 |
S1 |
p. 18
|
artikel
|
| 37 |
Duplex droplet digital PCR to study the composition of HIV-DNA in blood cells
|
Simonetti, F.R.
|
|
|
1 |
S1 |
p. 30
|
artikel
|
| 38 |
Effects of heme degradation products on reactivation of latent HIV-1
|
Melkova, Z.
|
|
|
1 |
S1 |
p. 42
|
artikel
|
| 39 |
Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR/Cas9 gene editing
|
Khalili, K.
|
|
|
1 |
S1 |
p. 16
|
artikel
|
| 40 |
Emergence of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy
|
Jerome, K.R.
|
|
|
1 |
S1 |
p. 16
|
artikel
|
| 41 |
Emerging results of an extensive survey of potential participants’ willingness to take risks in and donate to HIV cure research in the United States
|
Taylor, J.
|
|
|
1 |
S1 |
p. 13
|
artikel
|
| 42 |
Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies
|
Karn, J.
|
|
|
1 |
S1 |
p. 20-21
|
artikel
|
| 43 |
Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice
|
Marsden, M.D.
|
|
|
1 |
S1 |
p. 1
|
artikel
|
| 44 |
Evidence of ongoing HIV replication during suppressive antiretroviral therapy
|
Giron, L. Bertoni
|
|
|
1 |
S1 |
p. 29-30
|
artikel
|
| 45 |
Exosomes from HIV-1 infected cells stimulate production of pro-inflammatory cytokines through TAR RNA.
|
Sampey, G.C.
|
|
|
1 |
S1 |
p. 22
|
artikel
|
| 46 |
Ex vivo determination of stem cell transplantation graft-versus-HIV reservoir effects
|
Hogan, L.E.
|
|
|
1 |
S1 |
p. 19
|
artikel
|
| 47 |
Gene editing CCR5 in HIV subjects CD4 T cells
|
Ando, D.
|
|
|
1 |
S1 |
p. 11-12
|
artikel
|
| 48 |
Genetic and functional characterization of HIV-1 Nef gene from North Indian HIV-1 infected patients
|
Singh, J.
|
|
|
1 |
S1 |
p. 24
|
artikel
|
| 49 |
Genetic variation continues to occur in well-controlled HIV-1-infected patients
|
Dampier, W.
|
|
|
1 |
S1 |
p. 42
|
artikel
|
| 50 |
Hematopoietic stem and progenitor cells harbor provirus with identical Gag and V3 sequences as residual plasma virus in optimally treated patients
|
Terry, V.H.
|
|
|
1 |
S1 |
p. 34
|
artikel
|
| 51 |
HIV alters the profile of cytokines responding to seasonal influenza vaccination
|
González, L.
|
|
|
1 |
S1 |
p. 35
|
artikel
|
| 52 |
HIV antibodies as markers of HIV systemic reservoir and replication activity
|
Keating, S.M.
|
|
|
1 |
S1 |
p. 28
|
artikel
|
| 53 |
HIV conserved region vaccine in early cART-treated subjects (BCN01): impact on immunogenicity and the latent reservoir
|
Morón-López, S.
|
|
|
1 |
S1 |
p. 14-15
|
artikel
|
| 54 |
HIV isolated from CSF cells of a virologically controlled patient infects astrocytes
|
Li, G.H.
|
|
|
1 |
S1 |
p. 33
|
artikel
|
| 55 |
HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells
|
Spina, C.A.
|
|
|
1 |
S1 |
p. 4-5
|
artikel
|
| 56 |
HIV-1 mediated insertional activation of STAT5B promotes the formation of a viral reservoir in T regulatory cells
|
Cesana, D.
|
|
|
1 |
S1 |
p. 31
|
artikel
|
| 57 |
HIV persistence: to the periphery and beyond
|
Martinez, J.V. Garcia
|
|
|
1 |
S1 |
p. 1
|
artikel
|
| 58 |
HIV-1 silencing mediated by TRIM22 inhibition of Sp1 binding to the promoter
|
Vicenzi, E.
|
|
|
1 |
S1 |
p. 21
|
artikel
|
| 59 |
HIV-1 transcriptional latency in resting CD4 T-cell
|
Benkirane, M.
|
|
|
1 |
S1 |
p. 3
|
artikel
|
| 60 |
Human galectin-9 is a potent mediator of HIV transcription and reactivation
|
Abdel-Mohsen, M.
|
|
|
1 |
S1 |
p. 18
|
artikel
|
| 61 |
Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment
|
Vassallo, M.
|
|
|
1 |
S1 |
p. 32-33
|
artikel
|
| 62 |
Immune activation profile associated with comorbidities in successfully treated HIV infected patients
|
Psomas, C.
|
|
|
1 |
S1 |
p. 36-37
|
artikel
|
| 63 |
Immune control of HIV reservoirs and cure therapeutic strategies
|
Autran, B.
|
|
|
1 |
S1 |
p. 8
|
artikel
|
| 64 |
Immune response to sequences surrounding the 12 protease cleavage sites generated during ARV treatment improved CD4 counts of SIVmac251 infected rhesus monkeys
|
Luo, M.
|
|
|
1 |
S1 |
p. 15-16
|
artikel
|
| 65 |
Immunological properties of testicular tissue as an anatomical reservoir in ART-treated HIV-infected adults
|
Routy, J.P.
|
|
|
1 |
S1 |
p. 7-8
|
artikel
|
| 66 |
Impact of a decade of sustained antiretroviral therapy started during HIV-1 seroconversion on blood and gut reservoirs
|
Kinloch, S.
|
|
|
1 |
S1 |
p. 25
|
artikel
|
| 67 |
Impairment of the long-term ability of dolutegravir-resistant viruses to integrate
|
Wainberg, M.A.
|
|
|
1 |
S1 |
p. 40-41
|
artikel
|
| 68 |
Induction of HIV from latency by a novel molecule
|
Archin, N.M.
|
|
|
1 |
S1 |
p. 41
|
artikel
|
| 69 |
Ingenol derivatives are potent reactivators of latent HIV
|
Planelles, V.
|
|
|
1 |
S1 |
p. 22
|
artikel
|
| 70 |
Integrated and total HIV-1 DNA can predict quantitative viral outgrowth in patients on long-term ART
|
De Spiegelaere, W.
|
|
|
1 |
S1 |
p. 29
|
artikel
|
| 71 |
Integrated HIV DNA accumulates more rapidly in non-controllers than controllers
|
Pinzone, M.R.
|
|
|
1 |
S1 |
p. 25-26
|
artikel
|
| 72 |
Integration site analysis of latently infected cell lines: evidence of ongoing replication
|
Symons, J.
|
|
|
1 |
S1 |
p. 4
|
artikel
|
| 73 |
In vitro analysis of different PKC agonists: latency reversal, T-cell activation, cytokine production and isoform selectivity
|
Barnard, R.
|
|
|
1 |
S1 |
p. 38
|
artikel
|
| 74 |
In vivo expression of unspliced HIV RNA in expanded CD4+T-cell clones containing defective or replication-competent proviruses
|
Kearney, M.F.
|
|
|
1 |
S1 |
p. 6
|
artikel
|
| 75 |
In vivo suppression of SIV-mediated immune activation by a p38 MAPK inhibitor combined with ART
|
Aldovini, A.
|
|
|
1 |
S1 |
p. 2
|
artikel
|
| 76 |
Kinetics of HIV production by monocyte derived macrophages (MDM) in the presence of erythrocytes
|
Fazzi, L.
|
|
|
1 |
S1 |
p. 32
|
artikel
|
| 77 |
Latency-reversing agents and cellular activation affect antigen processing in primary CD4 T cells
|
Boucau, J.
|
|
|
1 |
S1 |
p. 10
|
artikel
|
| 78 |
LEDGF/p75 and Iws1 participate both cooperatively and independently to distinct steps of HIV transcription
|
Emiliani, S.
|
|
|
1 |
S1 |
p. 22-23
|
artikel
|
| 79 |
Levels of SAMHD1 and natural ribonucleotides may alter anti-HIV potency of antiretroviral agents in primary CD4+ CCR5+ placental macrophages
|
Gavegnano, C.
|
|
|
1 |
S1 |
p. 32
|
artikel
|
| 80 |
Limitations of employing antibody drug conjugates (ADCs) for targeting HIV infected cells as a strategy for hiv cure
|
Strizki, J.
|
|
|
1 |
S1 |
p. 39
|
artikel
|
| 81 |
Long-lived Th17 subsets contribute to HIV-1 persistence under ART
|
Ancuta, P.
|
|
|
1 |
S1 |
p. 9
|
artikel
|
| 82 |
Long-term spontaneous control of HIV-1 relates to low frequency of infected cells and inefficient viral reactivation
|
Prado, J.G.
|
|
|
1 |
S1 |
p. 8
|
artikel
|
| 83 |
Low viral reservoir treated patients (LoViReT): clinical predictors of low HIV-1 DNA
|
Salgado, M.
|
|
|
1 |
S1 |
p. 26-27
|
artikel
|
| 84 |
Lymphatic and cancer tissues are a potential reservoir of replicating virus in virally suppressed ART+ patients
|
Rose, R.
|
|
|
1 |
S1 |
p. 7
|
artikel
|
| 85 |
Lymphoid tissue and blood CD4 T cells respond differently to latency-reversing agents: are we testing the right cells?
|
Gramatica, A.
|
|
|
1 |
S1 |
p. 11
|
artikel
|
| 86 |
Memory CD4+ T cell subsets show differential responses to HIV latency-reversing agents
|
Kulpa, D.A.
|
|
|
1 |
S1 |
p. 2
|
artikel
|
| 87 |
Mild cognitive impairment in a clinically latent HIV-1 patient population
|
Devlin, K.N.
|
|
|
1 |
S1 |
p. 24
|
artikel
|
| 88 |
Mixed effects of HDACi on host gene expression and their implications for HIV reactivation from latency
|
Beliakova-Bethell, N.
|
|
|
1 |
S1 |
p. 4
|
artikel
|
| 89 |
Modulations in key defense responses of epithelial cells during co-stimulation with BCG and HIV-Nef
|
Mehto, S.
|
|
|
1 |
S1 |
p. 34
|
artikel
|
| 90 |
Molecular profiling of antigen-specific peripheral T follicular helper cells from HIV-infected donors using influenza vaccination model
|
de Armas, L.
|
|
|
1 |
S1 |
p. 35-36
|
artikel
|
| 91 |
Most tissues of a plasma-negative HIV autopsy cohort contain HIV DNA and many exhibit tissue pathology
|
Rose, R.
|
|
|
1 |
S1 |
p. 34
|
artikel
|
| 92 |
Multi-dose romidepsin in SIV-infected rhesus macaques (RMs) reactivates latent, replication-competent virus in the absence of antiretroviral therapy (ART)
|
Policicchio, B.
|
|
|
1 |
S1 |
p. 38-39
|
artikel
|
| 93 |
Neutraplex nanoparticles to target HIV reservoirs
|
Lavigne, C.
|
|
|
1 |
S1 |
p. 41
|
artikel
|
| 94 |
NNRTIs reduce HIV-1 production from latently infected resting CD4+ T cells
|
Zerbato, J.
|
|
|
1 |
S1 |
p. 19
|
artikel
|
| 95 |
No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV infected patients receiving suppressive maraviroc therapy
|
Izopet, J.
|
|
|
1 |
S1 |
p. 31-32
|
artikel
|
| 96 |
Novel CD4-based bi-specific chimeric antigen receptors: toward a functional cure of HIV infection
|
Bolivar-Wagers, S.
|
|
|
1 |
S1 |
p. 40
|
artikel
|
| 97 |
Pathogenicity of CD16+ monocyte-derived dendritic cells during HIV-1 infection
|
Wacleche, V.S.
|
|
|
1 |
S1 |
p. 36
|
artikel
|
| 98 |
Peripheral blood CD4+ T cells and intestinal lamina propria mononuclear cells contribute to viremia following an analytical treatment interruption: a follow-up analysis of the panobinostat trial
|
Barton, K.
|
|
|
1 |
S1 |
p. 30
|
artikel
|
| 99 |
Peripheral blood lymphocytes from patients with chronic myeloid leukemia on treatment with dasatinib are resistant to HIV-1 infection
|
Coiras, M.
|
|
|
1 |
S1 |
p. 17
|
artikel
|
| 100 |
Persistence of HIV-infected alveolar macrophages after suppressive ART
|
Hong, F.F.
|
|
|
1 |
S1 |
p. 8
|
artikel
|
| 101 |
Population genetic approaches to estimating the size of the HIV reservoir
|
Hattori, J.
|
|
|
1 |
S1 |
p. 27
|
artikel
|
| 102 |
Post-mortem analysis of HIV-1 reservoir after allogeneic transplantation using stem cells
|
Nijhuis, M.
|
|
|
1 |
S1 |
p. 27-28
|
artikel
|
| 103 |
Potent CTL responses to conserved element of HIV to improve therapeutic DNA vaccine efficacy
|
Felber, B.K.
|
|
|
1 |
S1 |
p. 15
|
artikel
|
| 104 |
Potential role for neutralizing antibodies in HIV-1 infection
|
Mascola, J.
|
|
|
1 |
S1 |
p. 14
|
artikel
|
| 105 |
Predicting determinants of long-term HIV control with gene therapy strategies
|
Hill, A.L.
|
|
|
1 |
S1 |
p. 41
|
artikel
|
| 106 |
Proliferation of perivascular macrophages in macaque models of lentiviral encephalitis: a potential mechanism for HIV/SIV persistence in the brain
|
Kim, W.K.
|
|
|
1 |
S1 |
p. 6-7
|
artikel
|
| 107 |
Quantifying the impact of autologous transplantation on viral reservoirs in a nonhuman primate model of HIV/AIDS
|
Peterson, C.W.
|
|
|
1 |
S1 |
p. 2-3
|
artikel
|
| 108 |
Reactivation of VOA-inducible and -uninducible HIV-1 proviruses using immune-compromised mice engrafted with human resting CD4+ T cells
|
Yuan, Z.
|
|
|
1 |
S1 |
p. 20
|
artikel
|
| 109 |
Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV
|
Hill, A.L.
|
|
|
1 |
S1 |
p. 13
|
artikel
|
| 110 |
Restricted HIV-1 diversity and clonal expansion following cytoreductive chemotherapy
|
Henrich, T.J.
|
|
|
1 |
S1 |
p. 17-18
|
artikel
|
| 111 |
Role of drug transporters and metabolic enzymes in antiretroviral drug (ARV) disposition in testicular tissue: potential contribution to HIV-1 persistence
|
Bendayan, R.
|
|
|
1 |
S1 |
p. 11
|
artikel
|
| 112 |
Sequential treatment with 5-aza-2′deoxycitidine and deacetylase inhibitors reactivates HIV
|
Van Lint, C.
|
|
|
1 |
S1 |
p. 39
|
artikel
|
| 113 |
Shining the RNA-Seq microscope on models of HIV latency
|
Woelk, C.H.
|
|
|
1 |
S1 |
p. 1-2
|
artikel
|
| 114 |
Significance of a novel residual HIV-1 variant longitudinally detected in plasma of a patient on suppressive antiretroviral therapy
|
Sahu, G.K.
|
|
|
1 |
S1 |
p. 25
|
artikel
|
| 115 |
Single-cell analysis identifies biomarkers for HIV permissiveness
|
Ciuffi, A.
|
|
|
1 |
S1 |
p. 3
|
artikel
|
| 116 |
SNPs within the HIV-1 LTR associate with increased virus persistence
|
Sullivan, N.T.
|
|
|
1 |
S1 |
p. 26
|
artikel
|
| 117 |
Strategies to overcome active and latent HIV: attack is the best way for defense
|
Shadad, H.
|
|
|
1 |
S1 |
p. 40
|
artikel
|
| 118 |
Suppression of the HIV-1 reservoir with a potent Tat inhibitor
|
Valente, S.
|
|
|
1 |
S1 |
p. 38
|
artikel
|
| 119 |
Sustained HIV release by single persisting CD4+ T cells during latency disruption
|
Hataye, J.M.
|
|
|
1 |
S1 |
p. 5-6
|
artikel
|
| 120 |
Targeting HIV reservoir by DART molecules that recruit T cells to HIV Env expressing cells: comparison of HIV arms derived from broadly reactive neutralizing or non-neutralizing anti-Env antibodies
|
Nordstrom, J.L.
|
|
|
1 |
S1 |
p. 14
|
artikel
|
| 121 |
The anti-inflammatory response and the HIV cure
|
Sekaly, R.
|
|
|
1 |
S1 |
p. 16
|
artikel
|
| 122 |
The effects of combination of ingenol-B and ART to SIV251 infected rhesus monkeys
|
dos Santos Goncalves, G.
|
|
|
1 |
S1 |
p. 16-17
|
artikel
|
| 123 |
The HIV-1 antisense transcript AST is an inducer of viral latency
|
Romerio, F.
|
|
|
1 |
S1 |
p. 3-4
|
artikel
|
| 124 |
The human lung is a site of productive HIV infection during long-term ART: novel tools to study ART-durable HIV reservoirs
|
Gludish, D.W.
|
|
|
1 |
S1 |
p. 7
|
artikel
|
| 125 |
The importance of GPP implementation in HIV cure research: learning from prevention
|
Handibode, J.
|
|
|
1 |
S1 |
p. 13
|
artikel
|
| 126 |
The steroid receptor coactivators are targets for reactivation of HIV latency
|
Nikolai, B.C.
|
|
|
1 |
S1 |
p. 23
|
artikel
|
| 127 |
The synergistic effect of PKA activator and HDAC inhibitor to reactivate HIV-1 provirus from latently infected cells
|
Choi, B.S.
|
|
|
1 |
S1 |
p. 24
|
artikel
|
| 128 |
The transcriptional program governed by RORγt favors HIV-1 replication in CCR4+CCR6+ Th17 cells
|
Wacleche, V.S.
|
|
|
1 |
S1 |
p. 10
|
artikel
|
| 129 |
The unique enrichment of histone modifications and its relationship with HIV-1 latency in some chromosomes
|
Kim, K.C.
|
|
|
1 |
S1 |
p. 21-22
|
artikel
|
| 130 |
The utility of the Connectivity Map (CMAP) for HIV cure strategies
|
Gunawardana, Y.P.
|
|
|
1 |
S1 |
p. 37-38
|
artikel
|
| 131 |
The virology of HIV-1 persistence: integration, expansion, and expression
|
Coffin, J.
|
|
|
1 |
S1 |
p. 5
|
artikel
|
| 132 |
Tissue localization of human T cell responses
|
Farber, D.
|
|
|
1 |
S1 |
p. 6
|
artikel
|
| 133 |
Towards achieving a state of reversible HIV-1 latency in primary monocyte-derived macrophages (MDM) by M1 polarization
|
Poli, G.
|
|
|
1 |
S1 |
p. 20
|
artikel
|
| 134 |
Towards HIV reservoir measurements in ART-treated patients: integrated DNA quantification and HIV-1 clone expansion in a Japanese cohort
|
Stanoeva, K.
|
|
|
1 |
S1 |
p. 25
|
artikel
|
| 135 |
Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5
|
Bosque, A.
|
|
|
1 |
S1 |
p. 12
|
artikel
|
| 136 |
Ultradeep sequencing characterization of HIV-1 diversity in primary infection
|
Delaugerre, C.
|
|
|
1 |
S1 |
p. 28
|
artikel
|
| 137 |
Uncovering mechanisms of HIV persistence in HIV controllers by HIV sequence analysis in CD4 T cell subsets
|
Boritz, E.
|
|
|
1 |
S1 |
p. 9-10
|
artikel
|
| 138 |
Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies
|
Nonnemacher, M.
|
|
|
1 |
S1 |
p. 42
|
artikel
|
| 139 |
Viral counteractions against CTIP2 in HIV-1 permissive cells
|
Forouzanfar, F.
|
|
|
1 |
S1 |
p. 21
|
artikel
|
| 140 |
Virologic and immunologic correlates of viral control after ART-interruption in SIV-infected rhesus macaques
|
Paiardini, M.
|
|
|
1 |
S1 |
p. 35
|
artikel
|
Tijdschrift beschrijving